An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation
- PMID: 18641363
- DOI: 10.4049/jimmunol.181.3.2227
An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation
Abstract
The expansion of the cytokine-producing CD56(bright) NK cell subset is a main feature of lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation (HSCT). We investigated phenotypes and functions of CD56(bright) and CD56(dim) NK subsets from 43 HLA-matched non-T cell-depleted HSCT donor-recipient pairs. The early expansion of CD56(bright) NK cells gradually declined in the posttransplant period but still persisted for at least 1 year and was characterized by the emergence of an unusual CD56(bright)CD16(low) subset with an intermediate maturation profile. The activating receptors NKG2D and NKp46, but also the inhibitory receptor NKG2A, were overexpressed compared with donor CD56(bright) populations. Recipient CD56(bright) NK cells produced higher amounts of IFN-gamma than did their respective donors and were competent for degranulation. Intracellular perforin content was increased in CD56(bright) NK cells as well as in T cells compared with donors. IL-15, the levels of which were increased in the posttransplant period, is a major candidate to mediate these changes. IL-15 serum levels and intracellular T cell perforin were significantly higher in recipients with acute graft-vs-host disease. Altogether, CD56(bright) NK cells postallogeneic HSCT exhibit peculiar phenotypic and functional properties. Functional interactions between this subset and T cells may be important in shaping the immune response after HSCT.
Similar articles
-
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation.Haematologica. 2018 Aug;103(8):1390-1402. doi: 10.3324/haematol.2017.186619. Epub 2018 Apr 26. Haematologica. 2018. PMID: 29700172 Free PMC article.
-
Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56brightCD16+NKp80+/-In-Vitro and Express KIR2DL2/DL3 and KIR3DL1.Front Immunol. 2021 May 4;12:640672. doi: 10.3389/fimmu.2021.640672. eCollection 2021. Front Immunol. 2021. PMID: 34017328 Free PMC article.
-
CD16- CD56+ natural killer cells after bone marrow transplantation.Blood. 1992 Jun 15;79(12):3239-44. Blood. 1992. PMID: 1375847
-
The biology of human natural killer-cell subsets.Trends Immunol. 2001 Nov;22(11):633-40. doi: 10.1016/s1471-4906(01)02060-9. Trends Immunol. 2001. PMID: 11698225 Review.
-
Role of chemokines in the biology of natural killer cells.Curr Top Microbiol Immunol. 2010;341:37-58. doi: 10.1007/82_2010_20. Curr Top Microbiol Immunol. 2010. PMID: 20369317 Review.
Cited by
-
Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation.Front Immunol. 2016 Apr 15;7:144. doi: 10.3389/fimmu.2016.00144. eCollection 2016. Front Immunol. 2016. PMID: 27148263 Free PMC article. Review.
-
Primary Immunodeficiencies Unravel the Role of IL-2/CD25/STAT5b in Human Natural Killer Cell Maturation.Front Immunol. 2018 Jun 22;9:1429. doi: 10.3389/fimmu.2018.01429. eCollection 2018. Front Immunol. 2018. PMID: 29988287 Free PMC article.
-
Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.Haematologica. 2014 Dec;99(12):1860-7. doi: 10.3324/haematol.2014.108407. Epub 2014 Aug 1. Haematologica. 2014. PMID: 25085354 Free PMC article.
-
Role for early-differentiated natural killer cells in infectious mononucleosis.Blood. 2014 Oct 16;124(16):2533-43. doi: 10.1182/blood-2014-01-553024. Epub 2014 Sep 9. Blood. 2014. PMID: 25205117 Free PMC article.
-
The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation.Front Immunol. 2024 May 16;15:1358668. doi: 10.3389/fimmu.2024.1358668. eCollection 2024. Front Immunol. 2024. PMID: 38817602 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials